{"id":"W1681160749","doi":"","title":"Chimerized functional anti-CD44 monoclonal antibody, ARH460-16-2, is more apogenic and has greater in vivo efficacy","year":2006,"lang":"en","type":"article","venue":"","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arius3D (Canada)","funders":"","keywords":"In vivo; Antibody; Monoclonal antibody; In vitro; Epitope; Apoptosis; CD44; Radioimmunotherapy; Growth inhibition; Cancer; Cancer research; Chemistry; Molecular biology; Immunology; Pharmacology; Medicine; Biology; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002218299,0.0003173777,0.0002749914,0.0001821185,0.00007122266,0.0003171291,0.0002252814,0.0004066917,0.002521897],"category_scores_gemma":[0.0001020638,0.0001150009,0.0002033756,0.000120573,0.0001320908,0.000213228,0.0001180199,0.0008511519,0.0005188504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004091944,"about_ca_system_score_gemma":0.0002477546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006968878,"about_ca_topic_score_gemma":0.0005599601,"domain_scores_codex":[0.9998168,0.00002364265,0.00001061973,0.00004567473,0.00006027271,0.00004294191],"domain_scores_gemma":[0.999869,0.00001174299,0.00003946222,0.00001446383,0.00002066625,0.00004468293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001690446,0.0001092916,0.0001442784,0.00002384574,0.000007466183,0.00001917155,0.00000654904,0.00006810785,0.9980046,0.0000608701,0.00008102677,0.001305724],"study_design_scores_gemma":[0.00009744577,0.001947277,0.00443024,0.00000567723,0.00003608431,0.000663506,0.00001573858,0.0009348386,0.9860423,0.00003691612,0.005784651,0.000005263153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935498,0.001160143,0.00275592,0.0001398806,0.00005999301,0.00002647226,0.0004496992,0.0001320396,0.001726014],"genre_scores_gemma":[0.9909288,0.0004572234,0.002481798,0.0001057031,0.00001748014,0.00002833881,0.0013263,0.00003075614,0.004623484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002521897,"threshold_uncertainty_score":0.00843662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03769541660159907,"score_gpt":0.3075617842614434,"score_spread":0.2698663676598443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}